JOINT FILING AGREEMENTJoint Filing Agreement • October 12th, 2021 • Ault Milton C Iii • Electronic components, nec
Contract Type FiledOctober 12th, 2021 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Class A Common Stock, $0.001 par value, of Ault Global Holdings, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • June 25th, 2021 • Ault Milton C Iii • Pharmaceutical preparations
Contract Type FiledJune 25th, 2021 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.0001 par value, of Alzamend Neuro, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • April 28th, 2022 • Ault Milton C Iii • Pharmaceutical preparations
Contract Type FiledApril 28th, 2022 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.0001 par value, of Alzamend Neuro, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
SETTLEMENT AGREEMENT AND RELEASE OF CLAIMSSettlement Agreement and Release of Claims • January 25th, 2024 • Ault Milton C Iii • Pharmaceutical preparations • New York
Contract Type FiledJanuary 25th, 2024 Company Industry JurisdictionTHIS SETTLEMENT AGREEMENT AND RELEASE OF CLAIMS (the “Settlement Agreement”) is made and entered into as of January 19, 2024, by and between ALZAMEND NEURO, INC. (“ALZN”), on the one hand, and AULT LIFE SCIENCES FUND, LLC (“ALSF”), on the other hand. ALZN and ALSF shall each individually be referred to as a “Party” and collectively, as the “Parties.”
JOINT FILING AGREEMENTJoint Filing Agreement • July 24th, 2024 • Ault Milton C Iii • Electronic components, nec
Contract Type FiledJuly 24th, 2024 Company IndustryIn accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Class A Common Stock, $0.001 par value per share, of Ault Alliance, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.